Fibrinogen | Participants(n) | unfavorable outcome events(mRS score ≥ 3) | Incidence of unfavorable outcome (95% CI) (%) |
---|---|---|---|
Total | 1851 | 526 | 28.42(26.1–30.3) |
Q1 | 436 | 111 | 24.18(28.4–37.2) |
Q2 | 443 | 112 | 24.35(26.0-34.5) |
Q3 | 442 | 128 | 27.89(21.5–29.6) |
Q4 | 443 | 175 | 37.00 (20.4–28.4) |
P for trend |  |  | < 0.001 |